The global epoetin-alfa erythropoietin market is witnessing steady expansion driven by rising chronic disease prevalence and the growing demand for anemia management therapies worldwide. Epoetin-alfa, a recombinant erythropoietin, is widely used to stimulate red blood cell production in patients suffering from chronic kidney disease (CKD), cancer-related anemia, HIV treatment-related anemia,...